Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Honors & Awards: Featured on: Michele Stephan-Arsenault handles product liability cases in state and federal courts throughout the country
Sleep, 47 (4), zsae003
Between our available member resources and our expert team of board-certified nutritionists and weight loss coaches, our programs empower members to not only lose weight but also build a solid foundation to sustain weight loss past the program
Phase 3: TRANSCEND-T2D-1 Results (May 2026) In May 2026, Eli Lilly released topline results from TRANSCEND-T2D-1, the first Phase 3 trial for retatrutide in adults with type 2 diabetes
Ask for the name and credentials
Benefits Beyond Weight Loss While weight loss is the most visible benefit of Retatrutide, the medication's true value extends significantly deeper, encompassing critical aspects of cognitive, cardiovascular, and metabolic health that are essential to longevity
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
